FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

154321000036100: betamethasone (as acetate) 2.71 mg / 1 mL + betamethasone (as sodium phosphate) 2.96 mg / 1 mL injection, 5 x 1 mL ampoules (medicinal product pack)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    733631000036117 betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, 5 x 1 mL ampoules en Synonym Active Case sensitive Australian Medicines Terminology module
    746161000036112 betamethasone (as acetate) 2.71 mg / 1 mL + betamethasone (as sodium phosphate) 2.96 mg / 1 mL injection, 5 x 1 mL ampoules (medicinal product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, 5 x 1 mL ampoules Is a medicinal product pack false Inferred relationship Some
    betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, 5 x 1 mL ampoules has MPUU betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, ampoule false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Celestone Chronodose injection: suspension, 5 x 1 mL ampoules Is a False betamethasone (as sodium phosphate) 2.96 mg/mL + betamethasone (as acetate) 2.71 mg/mL injection, 5 x 1 mL ampoules Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start